Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By <A HREF"http://www.biospace.com/news_subject… Source: BioSpace You Might Also Like BridgeBio Launches QED Therapeutics With $65M and an Abandoned Novartis Cancer Program January 29, 2018 CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments March 29, 2017 2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force February 12, 2017
BridgeBio Launches QED Therapeutics With $65M and an Abandoned Novartis Cancer Program January 29, 2018
CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments March 29, 2017
